dermatan sulfate has been researched along with Anemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arosio, P; Asperti, M; Benzi, M; Besson-Fournier, C; Campostrini, N; Coppin, H; Corbella, M; Finazzi, D; Girelli, D; Maccarinelli, F; Naggi, A; Poli, M | 1 |
1 other study(ies) available for dermatan sulfate and Anemia
Article | Year |
---|---|
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo.
Topics: Anemia; Animals; Bone Morphogenetic Protein 6; Cell Line; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Hep G2 Cells; Heparin; Hepcidins; Humans; Inflammation; Inflammation Mediators; Inhibitor of Differentiation Protein 1; Iron; Lipopolysaccharides; Mice; Mice, Knockout; Promoter Regions, Genetic; Spleen; Time Factors; Transcriptional Activation | 2014 |